 Adrenergic beta-2 Receptor Antagonists
"Adrenergic beta-2 Receptor Antagonists" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Drugs that bind to and block the activation of ADRENERGIC BETA-2 RECEPTORS.
| Descriptor ID |
D058672
|
| MeSH Number(s) |
D27.505.519.625.050.200.200.200 D27.505.696.577.050.200.200.200
|
| Concept/Terms |
Adrenergic beta-2 Receptor Antagonists- Adrenergic beta-2 Receptor Antagonists
- Adrenergic beta 2 Receptor Antagonists
- Adrenergic beta2-Antagonists
- Adrenergic beta2 Antagonists
- beta2-Antagonists, Adrenergic
- beta-2 Adrenergic Blocking Agents
- beta 2 Adrenergic Blocking Agents
- Adrenergic beta-2 Antagonists
- Adrenergic beta 2 Antagonists
- Antagonists, Adrenergic beta-2
- beta-2 Antagonists, Adrenergic
- Adrenergic beta-2 Receptor Blockers
- Adrenergic beta 2 Receptor Blockers
|
Below are MeSH descriptors whose meaning is more general than "Adrenergic beta-2 Receptor Antagonists".
Below are MeSH descriptors whose meaning is more specific than "Adrenergic beta-2 Receptor Antagonists".
This graph shows the total number of publications written about "Adrenergic beta-2 Receptor Antagonists" by people in this website by year, and whether "Adrenergic beta-2 Receptor Antagonists" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1997 | 0 | 2 | 2 | | 2002 | 0 | 1 | 1 | | 2003 | 0 | 2 | 2 | | 2007 | 0 | 1 | 1 | | 2011 | 2 | 0 | 2 |
To return to the timeline, click here.
Below are the most recent publications written about "Adrenergic beta-2 Receptor Antagonists" by people in Profiles.
-
Nguyen LP, Singh B, Okulate AA, Alfaro VY, Tuvim MJ, Dickey BF, Bond RA. Complementary anti-inflammatory effects of a ß-blocker and a corticosteroid in an asthma model. Naunyn Schmiedebergs Arch Pharmacol. 2012 Feb; 385(2):203-10.
-
Peng H, Bond RA, Knoll BJ. The effects of acute and chronic nadolol treatment on ß2AR signaling in HEK293 cells. Naunyn Schmiedebergs Arch Pharmacol. 2011 Feb; 383(2):209-16.
-
Bawa-Khalfe T, Altememi GF, Mandyam CD, Schwarz LA, Eikenburg DC, Standifer KM. The presence of beta2-adrenoceptors sensitizes alpha2A-adrenoceptors to desensitization after chronic epinephrine treatment. BMC Pharmacol. 2007 Dec 20; 7:16.
-
Baker JG, Hall IP, Hill SJ. Agonist and inverse agonist actions of beta-blockers at the human beta 2-adrenoceptor provide evidence for agonist-directed signaling. Mol Pharmacol. 2003 Dec; 64(6):1357-69.
-
Baker JG, Hall IP, Hill SJ. Influence of agonist efficacy and receptor phosphorylation on antagonist affinity measurements: differences between second messenger and reporter gene responses. Mol Pharmacol. 2003 Sep; 64(3):679-88.
-
Baker JG, Hall IP, Hill SJ. Pharmacological characterization of CGP 12177 at the human beta(2)-adrenoceptor. Br J Pharmacol. 2002 Oct; 137(3):400-8.
-
Milligan G, Bond RA. Inverse agonism and the regulation of receptor number. Trends Pharmacol Sci. 1997 Dec; 18(12):468-74.
-
Samama P, Bond RA, Rockman HA, Milano CA, Lefkowitz RJ. Ligand-induced overexpression of a constitutively active beta2-adrenergic receptor: pharmacological creation of a phenotype in transgenic mice. Proc Natl Acad Sci U S A. 1997 Jan 07; 94(1):137-41.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|